Role of indoleamine 2,3-dioxygenase 1 in immunosuppression of breast cancer  

作　　者：Pratyasha Sarangi 

机构地区：[1]School of Biotechnology,Kalinga Institute of Industrial Technology,Bhubaneswar,Odisha 751024,India

出　　处：《Cancer Pathogenesis and Therapy》2024年第4期246-255,共10页癌症发生与治疗（英文）

摘　　要：Breast cancer(BC)contributes greatly to global cancer incidence and is the main cause of cancer-related deaths among women globally.It is a complex disease characterized by numerous subtypes with distinct clinical manifestations.Immune checkpoint inhibitors(ICIs)are not effective in all patients and have been associated with tumor resistance and immunosuppression.Because amino acid(AA)-catabolizing enzymes have been shown to regulate immunosuppressive effects,this review investigated the immunosuppressive roles of indoleamine 2,3-dioxygenase 1(IDO1),a tryptophan(Trp)-catabolizing enzyme,which is overexpressed in various metastatic tumors.It promotes immunomodulatory effects by depleting Trp in the regional microenvironment.This leads to a reduction in the number of immunogenic immune cells,such as effector T and natural killer(NK)cells,and an increase in tolerogenic immune cells,such as regulatory T(Treg)cells.The BC tumor microenvironment(TME)establishes a supportive niche where cancer cells can interact with immune cells and neighboring endothelial cells and is thus a feasible target for cancer therapy.In many immunological contexts,IDO1 regulates immune control by causing regional metabolic changes in the TME and tissue environment,which may further affect the maturation of systemic immunological tolerance.In the development of effective treatment targets and approaches,it is essential to understand the immunomodulatory effects exerted by AA-catabolizing enzymes,such as IDO1,on the components of the TME.

关 键 词：IDO1 Breast cancer IDO1 inhibitor IMMUNOSUPPRESSION Tumor microenvironment 

分 类 号：R730.51[医药卫生—肿瘤]